{"id":51495,"date":"2026-04-19T10:42:30","date_gmt":"2026-04-19T10:42:30","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/51495\/"},"modified":"2026-04-19T10:42:30","modified_gmt":"2026-04-19T10:42:30","slug":"roche-falls-as-side-effects-data-for-obesity-drug-raises-concern","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/51495\/","title":{"rendered":"Roche Falls as Side Effects Data for Obesity Drug Raises Concern"},"content":{"rendered":"<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">Shares of <a href=\"https:\/\/www.bloomberg.com\/quote\/ROG:SW\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Roche Holding AG<\/a> fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company\u2019s experimental obesity medicine.<\/p>\n<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">The poster, released as part of this week\u2019s European Association for the Study of Diabetes <a href=\"https:\/\/www.easd.org\/annual-meeting\/easd-2024.html\" title=\"EASD website\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">annual meeting<\/a>, showed side effects including nausea, vomiting and diarrhea for Roche\u2019s injectable drug, CT-388. The stock fell as much as 4.5% in Zurich on Monday.<\/p>\n","protected":false},"excerpt":{"rendered":"Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the&hellip;\n","protected":false},"author":2,"featured_media":51496,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[22207,114,2112,10404,4397,197,23121,10622,231,304,29321,134,2843,789,74],"class_list":["post-51495","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-americas","tag-business","tag-cancer","tag-carmot-therapeutics-inc","tag-drugs","tag-europe","tag-industrials","tag-industries","tag-markets","tag-pharmaceutical","tag-prognosis","tag-roche","tag-science","tag-technology","tag-united-states"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116430959115685120","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/51495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=51495"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/51495\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/51496"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=51495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=51495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=51495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}